Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”

Joint Authors

López-Morales, Carlos A.
Miranda-Hernández, Mariana P.
Perdomo-Abúndez, Francisco C.
Revilla-Beltri, Jorge
Salazar-Flores, Rodolfo D.
Ramírez-Ibanez, Nancy D.
Molina-Pérez, Aaron
Pérez, Néstor O.
Medina-Rivero, Emilio
Flores-Ortiz, Luis F.

Source

Journal of Immunology Research

Issue

Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-3, 3 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2018-02-21

Country of Publication

Egypt

No. of Pages

3

Main Subjects

Biology

Abstract EN

This communication responds to the Letter to the Editor [1], where noticeably Messrs.

Brian Hassett, Steven Vicik, and Brian Fitzpatrick from Pfizer Biotech contended that a particular glycan profile, presented in comparison to different profiles, does not correspond to the historical profile of the reference medicinal product of etanercept (Enbrel®), as it is exposed.

American Psychological Association (APA)

Miranda-Hernández, Mariana P.& López-Morales, Carlos A.& Perdomo-Abúndez, Francisco C.& Salazar-Flores, Rodolfo D.& Ramírez-Ibanez, Nancy D.& Pérez, Néstor O.…[et al.]. 2018. Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”. Journal of Immunology Research،Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1192699

Modern Language Association (MLA)

Miranda-Hernández, Mariana P.…[et al.]. Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”. Journal of Immunology Research No. 2018 (2018), pp.1-3.
https://search.emarefa.net/detail/BIM-1192699

American Medical Association (AMA)

Miranda-Hernández, Mariana P.& López-Morales, Carlos A.& Perdomo-Abúndez, Francisco C.& Salazar-Flores, Rodolfo D.& Ramírez-Ibanez, Nancy D.& Pérez, Néstor O.…[et al.]. Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”. Journal of Immunology Research. 2018. Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1192699

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1192699